CRTAC1-A reprograms extracellular matrix viscoelasticity to constrain glioma progression
Varinder Singh, Devansh Swadia, Pritam Saha, Debasish Nath, Nilesh Deokate, Sabyasachi Rakshit
This study identifies CRTAC1-A as a regulator of ECM viscoelasticity that suppresses glioma progression by reducing matrix stiffness and enhancing drug penetration.
bioRxiv · May 9, 2026 · PreprintCancer Biology